Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Lakewood › NPI 1225133473
Hospital

Monmouth Medical Center INC

Monmouth Medical Center INC was paid $60.14M by Medicaid between Jan 2018 and Dec 2024, across 256 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoMONMOUTH MEDICAL CENTER INC
LAKEWOOD, NJ 08701
33aNPI1225133473assigned 09/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$60.14M
24GClaims663,162
24DCodes billed256
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#27 of 93
Median peer was paid$30.60M
This provider vs. median2.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201887,129$8.08M
201990,400$7.76M
202070,536$6.45M
202189,292$8.85M
2022118,407$9.52M
2023119,121$10.67M
2024incomplete88,277$8.82M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 24,831 22,998 $9.07M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 20,494 18,503 $8.41M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.6% 14,628 13,058 $5.80M
T2034 Crisis intervention, waiver; per diem 7.6% 5,344 5,026 $4.55M
S9480 Intensive outpatient psychiatric services, per diem 5.8% 4,383 3,964 $3.48M
G0378 Hospital observation service, per hour 4.0% 3,400 2,609 $2.39M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.5% 7,959 7,408 $2.13M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.5% 6,380 3,793 $1.50M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.3% 2,946 1,750 $1.36M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.8% 2,106 900 $1.09M
OP250 1.7% 54,494 31,058 $1.03M
80053 Comprehensive metabolic panel 1.6% 34,393 28,343 $957K
244 more codes
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.6% 633 $938K
71046 Radiologic examination, chest; 2 views 1.2% 9,031 $699K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.2% 9,712 $696K
77067 Screening mammography, bilateral, including computer-aided detection 1.1% 4,162 $638K
OP710 <1% 5,084 $577K
76642 <1% 2,049 $558K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 2,852 $553K
71045 Radiologic examination, chest; single view <1% 6,301 $500K
96361 Intravenous infusion, hydration; each additional hour <1% 10,894 $442K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,811 $421K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 2,739 $404K
92587 <1% 2,023 $391K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,399 $383K
OP370 <1% 3,120 $338K
OP272 <1% 9,691 $321K
96367 <1% 1,255 $304K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,822 $303K
70450 Computed tomography, head or brain; without contrast material <1% 5,085 $291K
93971 <1% 1,093 $283K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 179 $279K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,383 $276K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,080 $267K
96375 Therapeutic injection; each additional sequential IV push <1% 8,324 $267K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 12,896 $247K
36415 Collection of venous blood by venipuncture <1% 43,492 $246K
92555 <1% 1,993 $238K
92579 <1% 1,037 $233K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 34,766 $232K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,017 $226K
92567 <1% 2,363 $218K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 256 $211K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 7,961 $208K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,649 $200K
76536 <1% 637 $183K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,254 $181K
86850 <1% 2,981 $175K
50590 <1% 80 $172K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,374 $159K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,626 $153K
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 1,295 $153K
93975 <1% 394 $148K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,512 $143K
92582 <1% 598 $143K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,017 $139K
76641 <1% 233 $137K
76830 Ultrasound, transvaginal <1% 1,186 $132K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 434 $129K
72125 Computed tomography, cervical spine; without contrast material <1% 1,912 $119K
77065 Tomosynthesis, mammo <1% 853 $119K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,839 $117K
73630 <1% 1,611 $112K
73130 <1% 1,471 $101K
77066 Tomosynthesis, mammo <1% 493 $100K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,730 $97K
92557 <1% 465 $97K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 77 $94K
99213 Doctor's office visit, returning patient (routine) <1% 1,265 $93K
99214 Doctor's office visit, returning patient (more involved) <1% 1,014 $87K
86900 <1% 3,109 $86K
92550 <1% 730 $86K
OP258 <1% 25,854 $83K
73030 <1% 1,143 $83K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,425 $78K
82962 <1% 7,137 $78K
76770 <1% 466 $72K
93970 <1% 192 $67K
87081 <1% 2,163 $67K
97162 <1% 1,057 $62K
73562 <1% 803 $61K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,206 $60K
82247 <1% 1,749 $57K
A9270 Non-covered item or service <1% 9,425 $56K
73610 <1% 1,170 $54K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,749 $52K
72110 <1% 566 $49K
84443 Thyroid stimulating hormone (TSH) <1% 2,984 $49K
OP278 <1% 171 $45K
80048 Basic metabolic panel (calcium, ionized) <1% 3,064 $41K
86901 <1% 3,112 $40K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,657 $40K
78815 Positron emission tomography (PET) for limited area imaging <1% 29 $38K
87040 <1% 2,410 $37K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 37 $36K
84484 <1% 7,967 $35K
81001 <1% 7,015 $35K
96376 <1% 2,149 $34K
93976 <1% 428 $33K
74018 <1% 946 $32K
82248 <1% 3,226 $32K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 388 $32K
80061 Lipid panel <1% 1,778 $30K
85610 <1% 6,958 $29K
88312 <1% 560 $28K
J1756 Injection, iron sucrose, 1 mg <1% 1,219 $27K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 39 $27K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,858 $26K
85027 <1% 3,889 $25K
85730 <1% 6,435 $24K
73110 <1% 462 $24K
96415 <1% 94 $24K
87807 <1% 819 $23K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 887 $22K
81003 <1% 4,916 $22K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 103 $22K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 146 $22K
12001 <1% 690 $21K
85007 <1% 3,036 $20K
71275 Computed tomographic angiography, chest, with contrast material <1% 167 $19K
74021 <1% 353 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,395 $17K
81025 <1% 1,954 $16K
77080 <1% 82 $14K
83690 <1% 7,423 $14K
OP270 <1% 2,307 $14K
83735 <1% 3,859 $13K
83036 Hemoglobin; glycosylated (A1C) <1% 1,256 $13K
J2060 Injection, lorazepam, 2 mg <1% 1,108 $12K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 366 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,749 $12K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 263 $12K
90791 Psychiatric diagnostic evaluation <1% 515 $12K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,437 $12K
84439 <1% 661 $11K
J1644 Injection, heparin sodium, per 1000 units <1% 463 $11K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,269 $11K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,216 $10K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,448 $10K
88313 <1% 151 $9K
97597 <1% 16 $9K
87186 <1% 637 $8K
73590 <1% 99 $8K
82542 <1% 459 $7K
72100 <1% 228 $7K
J2704 Injection, propofol, 10 mg <1% 3,867 $7K
84702 <1% 965 $7K
86140 <1% 1,125 $7K
76882 <1% 26 $7K
80320 <1% 1,178 $7K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 63 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,402 $7K
80164 <1% 364 $6K
84703 <1% 1,709 $6K
OP255 <1% 1,066 $6K
80179 <1% 2,089 $6K
83605 <1% 828 $5K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 167 $5K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,255 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 135 $5K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 181 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,616 $5K
97802 <1% 39 $5K
92586 <1% 27 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,759 $5K
97014 <1% 86 $4K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 111 $4K
85651 <1% 727 $4K
73502 <1% 115 $4K
95886 <1% 14 $4K
97161 <1% 88 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 943 $4K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 421 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 563 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,687 $4K
C1781 Mesh (implantable) <1% 13 $4K
M0244 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency <1% 66 $4K
80329 <1% 465 $4K
92611 <1% 35 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,208 $3K
90715 <1% 715 $3K
80143 <1% 892 $3K
90792 Psychiatric diagnostic evaluation with medical services <1% 52 $3K
74022 <1% 42 $3K
76870 <1% 14 $3K
83880 <1% 328 $2K
73090 <1% 69 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 15 $2K
87070 <1% 160 $2K
85378 <1% 737 $2K
73564 <1% 52 $2K
80076 <1% 272 $2K
76775 <1% 13 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 504 $2K
85380 <1% 365 $2K
87088 <1% 483 $2K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 68 $2K
82550 <1% 979 $1K
77072 <1% 14 $1K
70486 <1% 13 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,287 $1K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 44 $1K
76801 <1% 14 $1K
74230 <1% 38 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 276 $1K
94760 <1% 213 $1K
84100 <1% 306 $1K
87205 <1% 163 $1K
OP637 <1% 690 $925.97
12002 <1% 17 $916.20
71101 <1% 12 $850.97
88304 <1% 94 $830.49
73080 <1% 26 $783.46
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 23 $745.40
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 16 $733.32
0002A <1% 22 $718.18
0001A <1% 21 $688.36
87077 <1% 121 $630.56
90674 <1% 15 $559.17
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 646 $548.89
85652 <1% 181 $533.97
C1769 Guide wire <1% 157 $438.34
77002 <1% 12 $422.90
86617 <1% 12 $370.43
87400 <1% 20 $325.78
74019 <1% 13 $314.12
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 263 $283.89
G0008 Administration of influenza virus vaccine <1% 17 $234.32
82607 <1% 30 $226.75
88300 <1% 43 $200.24
29515 <1% 12 $158.25
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 176 $129.88
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 488 $129.19
J1815 Injection, insulin, per 5 units <1% 21 $127.44
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 324 $94.90
82150 <1% 63 $89.50
87581 <1% 23 $81.70
87486 <1% 23 $81.70
75571 <1% 20 $70.63
J3360 Injection, diazepam, up to 5 mg <1% 39 $69.76
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 64 $64.89
83550 <1% 14 $42.26
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 99 $35.57
J1630 Injection, haloperidol, up to 5 mg <1% 185 $32.89
83540 <1% 14 $30.93
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 64 $23.17
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 59 $20.00
J7510 Prednisolone oral, per 5 mg <1% 215 $17.77
82553 <1% 18 $16.00
Q0222 Injection, bebtelovimab, 175 mg <1% 16 $2.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 13 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 14 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 0% 12 $0.00
29125 0% 12 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 0% 12 $0.00
J3535 Drug administered through a metered dose inhaler 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCARNEY, ERIC (CEO)
Parent organizationRWJ BARNABAS HEALTH INC
Same official

Other billing entities under CARNEY, ERIC

Full network →
ProviderLocationPaid
Monmouth Medical Center INCLong Branch, NJ$110.02M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.